Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma

@article{Graeven1999SerumLO,
  title={Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma},
  author={Ullrich Graeven and Niko Andre and Eike Achilles and Carsten Zornig and Wolff Schmiegel},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={1999},
  volume={125},
  pages={577-581}
}
Purpose: Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) have been suggested to be important mediators for tumor-induced angiogenesis. We measured serum VEGF and bFGF levels from patients with soft-tissue sarcomas and correlated serum VEGF and bFGF levels with tumor status at surgery and histological grading. Materials and methods: A group of 18 healthy controls and 85 patients with soft-tissue sarcoma were enrolled in this study. The patients were classified… CONTINUE READING